paclitaxel has been researched along with Disease, Pulmonary in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (46.67) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, CF; Chakroun, RW; Cui, H; Mitrut, RE; Su, H | 1 |
| Buckley, B; Caffrey, PB; Frenkel, GD; Gibbon, DG; Gounder, M; Hellmann, M; Kane, MP; Kumaran, MN; Nieves-Neira, W; Rodriguez-Rodriguez, L; Shih, W; Song, M; Vaidya, A | 1 |
| Brahmer, J; Dimery, I; Gray, R; Johnson, DH; Samant, M; Sandler, AB; Schiller, JH; Wang, LI | 1 |
| Chalfant, CE; Goehe, RW; Hawkins, AJ; Massiello, A; Mayton, EK; Mukerjee, P; Murudkar, CS; Park, MA; Pinkerman, RL; Shultz, JC; Wijesinghe, DS | 1 |
| Agelaki, S; Georgoulias, V; Kakolyris, S; Kalbakis, K; Kotsakis, A; Kouroussis, C; Mavroudis, D; Samonis, G; Souglakos, J; Vlachonikolis, J | 1 |
| Belani, CP; Bhatnagar, A; Flickinger, JC; Greenberger, JS; Ramalingam, S; Wolski, MJ | 1 |
| Oxnard, GR | 1 |
| Bajada, CL; Juillard, GJ; Parker, RG; Schweitzer, VG | 1 |
| Belani, CP; Holbert, JM; Ramanathan, RK; Reddy, VV | 1 |
| Akerley, W | 1 |
| Faoro, C; Goerg, C; Havemann, K; Kettner, H; Pfab, R; Wolf, M | 1 |
| Bonomi, P; Faber, LP; LaFollette, S; Lincoln, S; Recine, D; Sharma, M; Warren, W | 1 |
| Ding, A; Jin, F; Nathan, CF; Radzioch, D | 1 |
| Grinblatt, DL; Malloy, R; Williams, SF; Zimmerman, TM | 1 |
| Dafni, U; Dimopoulos, MA; Dimopoulou, I; Galani, H; Roussos, C; Samakovii, A | 1 |
5 trial(s) available for paclitaxel and Disease, Pulmonary
| Article | Year |
|---|---|
Phase I trial of selenium plus chemotherapy in gynecologic cancers.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cell Line, Tumor; Chemotherapy-Induced Febrile Neutropenia; DNA-Binding Proteins; Down-Regulation; Female; Gene Expression; Glutathione Peroxidase; Humans; Infections; Lung Diseases; Maximum Tolerated Dose; Middle Aged; Nervous System Diseases; Ovarian Neoplasms; Paclitaxel; Response Evaluation Criteria in Solid Tumors; RNA-Binding Proteins; Selenious Acid; Selenium; Selenoprotein P | 2018 |
Retrospective evaluation of the clinical and radiographic risk factors associated with severe pulmonary hemorrhage in first-line advanced, unresectable non-small-cell lung cancer treated with Carboplatin and Paclitaxel plus bevacizumab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Cohort Studies; Hemorrhage; Humans; Lung Diseases; Lung Neoplasms; Paclitaxel; Radiography; Retrospective Studies; Risk Factors | 2009 |
Phase I/II trial of weekly paclitaxel in patients with advanced lung cancer.
Topics: Alopecia; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Drug Eruptions; Drug Tolerance; Humans; Lung Diseases; Lung Neoplasms; Muscular Diseases; Neoplasm Metastasis; Neutropenia; Paclitaxel; Peripheral Nervous System Diseases | 1996 |
Postoperative bronchopulmonary complications in stage III lung cancer patients treated with preoperative paclitaxel-containing chemotherapy and concurrent radiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Lung Diseases; Lung Neoplasms; Male; Neoplasm Staging; Paclitaxel; Pneumonectomy; Postoperative Complications; Radiotherapy; Radiotherapy Dosage | 1997 |
A Phase I dose escalation trial of continuous infusion paclitaxel to augment high dose cyclophosphamide and thiotepa plus stem cell rescue for the treatment of patients with advanced breast carcinoma.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Breast Neoplasms; Carcinoma; Cohort Studies; Cyclophosphamide; Diarrhea; Esophagitis; Female; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Incidence; Infusions, Intravenous; Lung Diseases; Middle Aged; Neoplasm Staging; Paclitaxel; Pulmonary Alveoli; Remission Induction; Stomatitis; Survival Rate; Thiotepa; Transplantation, Autologous | 1998 |
10 other study(ies) available for paclitaxel and Disease, Pulmonary
| Article | Year |
|---|---|
Interface-Enrichment-Induced Instability and Drug-Loading-Enhanced Stability in Inhalable Delivery of Supramolecular Filaments.
Topics: Administration, Inhalation; Aerosols; Antineoplastic Agents, Phytogenic; Coumarins; Drug Delivery Systems; Drug Stability; Humans; Lung Diseases; Lung Neoplasms; Macromolecular Substances; Nanostructures; Paclitaxel; Particle Size; Peptides; Small Molecule Libraries; Surface Properties; Thiazoles | 2019 |
SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells.
Topics: Alternative Splicing; Carcinoma, Non-Small-Cell Lung; Caspase 9; Cell Line, Tumor; Cisplatin; Daunorubicin; Drug Resistance, Neoplasm; Drug Synergism; Enhancer Elements, Genetic; Erlotinib Hydrochloride; HeLa Cells; Humans; Introns; Lung Diseases; Nuclear Proteins; Paclitaxel; Quinazolines; RNA Precursors; RNA Splice Sites; RNA-Binding Proteins; RNA, Antisense; RNA, Small Interfering; Serine-Arginine Splicing Factors | 2011 |
Nonneutropenic febrile episodes associated with docetaxel-based chemotherapy in patients with solid tumors.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Candidiasis; Cytomegalovirus Infections; Docetaxel; Fever; Herpesviridae Infections; Humans; Infections; Lung Diseases; Lymphopenia; Neoplasms; Paclitaxel; Pneumonia, Pneumocystis; Prospective Studies; T-Lymphocytopenia, Idiopathic CD4-Positive; Taxoids | 2002 |
Multivariate analysis of survival, local control, and time to distant metastases in patients with unresectable non-small-cell lung carcinoma treated with 3-dimensional conformal radiation therapy with or without concurrent chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Esophageal Diseases; Follow-Up Studies; Humans; Lung Diseases; Lung Neoplasms; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Radiotherapy, Adjuvant; Radiotherapy, Conformal; Retrospective Studies; Survival Analysis | 2005 |
Bevacizumab for non-small-cell lung cancer.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Hemoptysis; Hemorrhage; Humans; Lung Diseases; Lung Neoplasms; Paclitaxel; Risk Factors; Survival Analysis | 2007 |
Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dermatitis; Female; Humans; Lung Diseases; Lung Neoplasms; Middle Aged; Paclitaxel; Radiation Injuries; Radiotherapy | 1995 |
Pulmonary infiltrates following administration of paclitaxel.
Topics: Aged; Antineoplastic Agents, Phytogenic; Drug Hypersensitivity; Female; Humans; Lung; Lung Diseases; Male; Middle Aged; Paclitaxel; Radiography | 1996 |
Paclitaxel and simultaneous radiation in the treatment of stage IIIA/B non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Administration Schedule; Drug Tolerance; Esophagitis; Female; Humans; Leukopenia; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pneumocystis Infections; Radiotherapy Dosage; Treatment Outcome | 1996 |
Lipopolysaccharide-related stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitor.
Topics: Animals; Enzyme Induction; Escherichia coli; Female; Genes, Immediate-Early; Interleukin-10; Interleukin-6; Lipopolysaccharides; Lung Diseases; Macrophages; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Paclitaxel; Protein Biosynthesis; Proteinase Inhibitory Proteins, Secretory; Proteins; Pseudomonas Infections; Secretory Leukocyte Peptidase Inhibitor; Staphylococcus aureus | 1998 |
A prospective study of pulmonary function in patients treated with paclitaxel and carboplatin.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Arteries; Carbon Monoxide; Carboplatin; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Lung; Lung Diseases; Male; Middle Aged; Ovarian Neoplasms; Paclitaxel; Prospective Studies; Pulmonary Diffusing Capacity; Respiratory Function Tests; Urinary Bladder Neoplasms | 2002 |